Table 4.
Association between scenario, patient and cancer characteristics and non-timely diagnosis.
| Number of Patients | Time to Diagnosis | Predictors of a Non-Timely Diagnosis, Odds Ratio (95% CI) |
|||||
|---|---|---|---|---|---|---|---|
| Total N |
Non-Timely Diagnosis n (%) |
Median Days (IQR) | Crude ORs | p-Value * | Adjusted ORs | p-Value * | |
| Cancer site | |||||||
| Bladder | 1713 | 418 (24.4) | 51 (33–90) | Reference | <0.0001 | Reference | <0.0001 |
| Kidney | 311 | 115 (37.0) | 70 (41–115) | 1.82 (1.41, 2.35) | 2.00 (1.52, 2.63) | ||
| UTUC | 81 | 38 (46.9) | 85 (57–137) | 2.74 (1.75, 4.29) | 2.75 (1.72, 4.38) | ||
| Scenario | |||||||
| Visible haematuria | 305 | 54 (17.7) | 50 (30–79) | Reference | <0.0001 | Reference | <0.0001 |
| Unspecified haematuria | 1373 | 173 (45.3) | 52 (33–89) | 1.48 (1.08, 2.04) | 1.43 (1.04, 1.98) | ||
| Recurrent UTIs | 382 | 332 (24.2) | 83 (43–151) | 3.85 (2.69, 5.49) | 3.46 (2.40, 5.00) | ||
| Abdominal mass | 45 | 12 (26.7) | 60 (26–92) | 1.69 (0.82, 3.48) | 1.03 (0.49, 2.20) | ||
| Sex | |||||||
| Male | 1511 | 365 (24.2) | 52 (33–89) | Reference | <0.0001 | Reference | 0.0112 |
| Female | 594 | 206 (34.7) | 65 (37–119) | 1.67 (1.36, 2.05) | 1.33 (1.07, 1.66) | ||
| Age group | |||||||
| <35 | 7 | 2 (28.6) | 46 (22–93) | 1.02 (0.20, 5.29) | 0.1325 | 1.31 (0.24, 7.04) | 0.0471 |
| 35–44 | 32 | 8 (25.0) | 60.5 (42.5–90) | 0.85 (0.37, 1.92) | 0.75 (0.32, 1.73) | ||
| 45–54 | 141 | 25 (17.7) | 52 (34–78) | 0.55 (0.35, 0.87) | 0.48 (0.30, 0.77) | ||
| 55–64 | 330 | 80 (24.2) | 50 (30–88) | 0.81 (0.60, 1.10) | 0.83 (0.61, 1.14) | ||
| 65–74 | 688 | 194 (28.2) | 56 (35–97) | Reference | Reference | ||
| 75–84 | 664 | 188 (28.3) | 56 (34–101) | 1.01 (0.79, 1.27) | 1.05 (0.82, 1.34) | ||
| 85+ | 243 | 74 (30.5) | 61 (38–126) | 1.11 (0.81, 1.54) | 1.06 (0.76, 1.48) | ||
CI: Confidence interval; IQR: Interquartile range; ORs: Odds ratios; UTI: Urinary tract infections; UTUC: Upper tract urothelial cancer. * Joint Wald tests performed for categorical variables.